Association study of candidate gene polymorphisms with amnestic mild cognitive impairment in a Chinese population

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Liu, Xiaoyan ^a,b   Yue, Chunxian ^a,b   Xu, Zhi ^b   Shu, Hao ^a,b   Pu, Mengjia ^a,b   Yu, Hui ^a   Shi, Yongmei ^a,b   Zhuang, Liying ^a,b   Xu, Xiaohui ^a,b   Zhang, Zhijun ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; TAU PROTEIN; UROKINASE;

AGED; APOLIPOPROTEIN E GENE; ARTICLE; CH25H GENE; CHINESE; CHOLESTEROL METABOLISM; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE MAP; HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MILD COGNITIVE IMPAIRMENT; MOLECULAR PATHOLOGY; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STH GENE; TAU GENE; TOMM40 GENE; UROKINASE GENE;

ALLELES; AMNESIA; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; EPISTASIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MILD COGNITIVE IMPAIRMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

EID: 84864108120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041198     Document Type: Article

References (26)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 56: 303-308.
2. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, et al. (2006) International Psychogeriatric Association Expert Conference on mild cognitive impairment. Lancet. 367: 1262-1270.
3. Perry EK, (1986) The cholinergic hypothesis-ten years on. Br Med Bull. 42: 63-69.
4. Glenner GG, Wong CW, (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
5. Wang JZ, Grundke-Iqbal I, Iqbal K, (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25: 59-68.
6. Benarroch EE, (2008) Brain cholesterol metabolism and neurologic disease. Neurology 71: 1368-1373.
7. Lehmann DJ, Johnston C, Smith AD, (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet 6: 1933-1936.
8. Ehehalt R, Keller P, Haass C, Thiele C, Simons K, (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160: 113-123.
9. Gotz J, Chen F, van Dorpe J, Nitsch RM, (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293: 1491-1495.
10. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A, (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99: 6364-6369.
11. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421.
12. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, et al. (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 10: 375-384.
13. Yu CE, Seltman H, Peskind ER, Galloway N, Zhou PX, et al. (2007) Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics 89: 655-665.
14. Han MR, Schellenberg GD, Wang LS, (2010) Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study. BMC Neurol 10: 90.
15. Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, et al. (2004) Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 75: 669-677.
16. Wijsman EM, Daw EW, Yu CE, Payami H, Steinbart EJ, et al. (2004) Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75: 398-409.
17. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, et al. (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137: 149-155.
18. Lamsa R, Helisalmi S, Herukka SK, Tapiola T, Pirttila T, et al. (2008) Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Neurobiol Aging 29: 848-855.
19. Park K, Scott AL, (2010) Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J Leukoc Biol 88: 1081-1087.
20. Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, et al. (2006) A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum Mol Genet 15: 2446-2456.
21. Finckh U, van Hadeln K, Muller-Thomsen T, Alberici A, Binetti G, et al. (2003) Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics 4: 213-217.
22. Song WJ, Sternberg LR, Kasten-Sportes C, Keuren ML, Chung SH, et al. (1996) Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region" Genomics 38: 331-339.
23. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, et al. (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16: 15-23.
24. Acquati F, Accarino M, Nucci C, Fumagalli P, Jovine L, et al. (2000) The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett 468: 59-64.
25. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H, (2000) BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci U S A 97: 9712-9717.
26. Cheon MS, Dierssen M, Kim SH, Lubec G, (2008) Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 35: 339-343.